Automated Immunoassay Analyzers Market Research 2026: Market Size, Trends, Segments And Growth Forecast
Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Automated Immunoassay Analyzers Market Forecast: Value Set To Climb From $26.39 Billion To $44.93 Billion
The market size for automated immunoassay analyzers has experienced rapid expansion in recent years. This market is expected to expand from $23.09 billion in 2025 to $26.39 billion in 2026, at a compound annual growth rate (CAGR) of 14.3%. The historical growth of this market can be attributed to the expansion of centralized clinical laboratories, growth in routine immunoassay testing volumes, increasing disease screening programs, early automation of laboratory workflows, and the adoption of immunoassay systems for infectious disease monitoring.
The automated immunoassay analyzers market size is projected to experience substantial growth in the next few years, expanding to $44.93 billion by 2030 at a compound annual growth rate (CAGR) of 14.2%. This growth during the forecast period is driven by factors such as increasing testing requirements for chronic and endocrine disorders, the growing demand for oncology and biomarker testing, the need for faster diagnostic results, the rising integration of automated platforms in research laboratories, and the expansion of pharmaceutical and biotech research and development testing applications. Key trends anticipated in the forecast period include a heightened demand for high-throughput diagnostic testing, increased adoption in infectious disease and endocrinology testing, the proliferation of automated testing in research and academic laboratories, greater utilization in therapeutic drug monitoring and oncology diagnostics, and the standardization of laboratory workflows to enhance testing efficiency.
Get A Free Sample Report With In-Depth Market Insights:
Automated Immunoassay Analyzers Market Development Factors: What’s Supporting Demand?
The expanding count of hospitals is anticipated to drive the future expansion of the automated immunoassay analyzers market. Hospitals are defined as healthcare facilities offering medical, surgical, and diagnostic services to individuals needing treatment or emergency attention. These establishments operate as structured environments, manned by healthcare experts, to deliver both inpatient and outpatient services across a range of medical fields. The growth in hospital numbers stems from heightened healthcare demands from an expanding and aging demographic. Automated immunoassay analyzers boost efficiency and precision within hospitals by quickly processing extensive quantities of diagnostic tests for a multitude of illnesses and conditions. For example, data from the American Health Care Association, a US-based nonprofit organization, indicated that in May 2023, the number of hospitals in the US rose to 6,129 in 2023 from 6,093 in 2022, representing an increase of 0.59%. Consequently, the growing count of hospitals is fueling the expansion of the automated immunoassay analyzers market.
Automated Immunoassay Analyzers Market Segment Landscape And Growth Outlook
The automated immunoassay analyzers market covered in this report is segmented –
1) By Product: Immunofluorescence, Chemiluminescence, Enzyme Linked Fluorescent System (ELISA), Multiplexed Assay System, Radioimmunoassay
2) By Application: Infectious Diseases, Endocrinology, Drug Monitoring, Cardiology, Oncology, Allergy Testing, Other Applications
3) By End-User: Hospitals, Diagnostic Laboratories, Research And Academic Laboratories, Pharmaceutical And Biotechnology Companies, Other End-Users
Subsegments:
1) By Immunofluorescence: Fluorescent Labeling Kits, Fluorescent Detectors And Readers, Immunofluorescence Reagents
2) By Chemiluminescence: Chemiluminescent Labels And Reagents, Chemiluminescence Detectors And Readers, Chemiluminescent Assay Kits
3) By Enzyme Linked Fluorescent System (ELISA): ELISA Kits (Capture And Detection Kits), ELISA Microplates And Plates Coating Systems, Enzyme Substrates And Detection Reagents
4) By Multiplexed Assay System: Multiplexed Assay Kits, Multi-Analyte Detection Systems, Multiplexing Software And Data Analysis Tools
5) By Radioimmunoassay (RIA): Radioactive Isotope Kits, Gamma Counters, Radiolabeled Reagents
Automated Immunoassay Analyzers Market Transformation Trends: What Innovations Are Driving Change?
Leading businesses within the automated immunoassay analyzers market are concentrating on creating novel offerings, including compact immunoassay analyzers, to secure an edge over competitors. These compact analyzers are smaller, easily transportable instruments built for performing immunoassay examinations to identify particular biomarkers within biological specimens. They provide ease of use and streamlined operation across diverse healthcare environments, especially in situations where room and movement are restricted. As an illustration, in July 2023, Siemens Healthineers, a healthcare firm based in Germany, introduced the Atellica CI Analyzer, which is a compact laboratory analysis system intended to boost efficiency in both immunoassay and clinical chemistry evaluations. By integrating these two testing approaches into one unified platform, the Atellica CI Analyzer addresses the increasing need for adaptable systems able to execute a range of tests effectively. This product’s characteristics are highly consistent with present market tendencies, successfully tackling the difficulties laboratories encounter in providing prompt and precise diagnostic outcomes. Features such as random access sampling, aspiration of micro-volumes, and automated scheduling for maintenance and quality control help laboratories attain more uniform and foreseeable sample processing durations.
Automated Immunoassay Analyzers Market Key Players Shaping Industry Direction
Major companies operating in the automated immunoassay analyzers market are Roche Diagnostics AG, Abbott Laboratories, Danaher Corporation, Siemens Healthineers, Becton Dickinson and Company, Tosoh Corporation, bioMérieux SA, QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc, Qiagen NV, Werfen Group SA, DiaSorin SpA, Bio-Techne Corporation, Meril Life Sciences Private Limited, Randox Laboratories Ltd, Getein Biotech Inc, Aesku Diagnostics GmbH & Co KG, Carolina Liquid Chemistries Corporation, Chengdu Seamaty Technology Co Ltd, Hipro Biotechnology Co Ltd
View The Full Automated Immunoassay Analyzers Market Report:
Automated Immunoassay Analyzers Market Regional Analysis: Which Geography Leads On Revenue?
North America was the largest region in the automated immunoassay analyzer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated immunoassay analyzers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.
